Biblio

Export 1 results:

] Title Type Year

Filters: Author is Heckman, Caroline A [Clear All Filters]

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

H

Heckman CA, Holopainen T, Wirzenius M, Keskitalo S, Jeltsch M, Ylä-Herttuala S, et al.. The tyrosine kinase inhibitor cediranib blocks ligand-induced vascular endothelial growth factor receptor-3 activity and lymphangiogenesis. Cancer Res [Internet]. 2008;68(12):4754 - 62. http://view.ncbi.nlm.nih.gov/pubmed/18559522

Caroline Heckman et al., Cancer Research 2008 (504.8 KB)